4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-23-053344
Chief Financial Officer acquired 47,249 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2023-10-19 | Option exercise | +47,249 | $0.14 | $6,615 | 621,195 | D |
| Derivatives | |||||||
| Byam Rebecca Chief Financial Officer | 2023-10-19 | Option exercise · Stock Option Grant (Right to Buy) | −47,249 | 0 | D | ||
Loading xslF345X05/doc4.xml…